3,4-dihydroxyphenylacetic acid has been researched along with olanzapine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bymaster, FP; Zhang, W | 1 |
| Altar, CA; Dunn, R; Jordan, S; Kikuchi, T; Koprivica, V; Tottori, K | 1 |
| Adamson, B; Arjona, AA; Wurtman, RJ; Zhang, SX | 1 |
| Benvenga, MJ; Bymaster, FP; Calligaro, DO; Cohen, IR; Falcone, JF; Hemrick-Luecke, SK; Martin, FM; Moore, NA; Nelson, DL; Nisenbaum, LK; Rasmussen, K; Schaus, JM; Sundquist, SJ; Tupper, DE; Wiernicki, TR | 1 |
| Gołembiowska, K; Kus, K; Nowakowska, E; Noworyta-Sokołowska, K; Ratajczak, P; Woźniak, A; Zaprutko, T | 1 |
5 other study(ies) available for 3,4-dihydroxyphenylacetic acid and olanzapine
| Article | Year |
|---|---|
The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Benzodiazepines; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Olanzapine; Phosphatidylinositols; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Muscarinic; Receptors, Neurotransmitter; Receptors, Serotonin; Serotonin Antagonists | 1999 |
In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cerebral Cortex; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Microdialysis; Neostriatum; Olanzapine; Piperazines; Prefrontal Cortex; Quinolones; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin | 2004 |
An animal model of antipsychotic-induced weight gain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Body Weight; Brain Chemistry; Chromatography, High Pressure Liquid; Darkness; Dopamine; Eating; Electrochemistry; Female; Food Preferences; Homovanillic Acid; Hydroxyindoleacetic Acid; Models, Animal; Motor Activity; Olanzapine; Photoperiod; Rats; Rats, Sprague-Dawley; Serotonin; Time Factors; Weight Gain | 2004 |
Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Catalepsy; Cocaine; Corticosterone; Drug Evaluation, Preclinical; Electrochemistry; Electrophysiology; Fasting; Female; Immunohistochemistry; Male; Molecular Structure; Motor Activity; Nucleus Accumbens; Olanzapine; Piperazines; Prolactin; Quipazine; Radioligand Assay; Rats; Rats, Inbred F344; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Histamine H1; Serotonin Receptor Agonists; Thiophenes; Time Factors | 2005 |
The influence of aripiprazole and olanzapine on neurotransmitters level in frontal cortex of prenatally stressed rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dopamine; Female; Frontal Lobe; Hydroxyindoleacetic Acid; Neurotransmitter Agents; Norepinephrine; Olanzapine; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Wistar; Serotonin; Stress, Physiological; Stress, Psychological | 2016 |